We are live on ! Find out more
Wells Fargo

Wells Fargo Portfolio holdings

AUM $530B
1-Year Est. Return 22.01%
 

Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.

This Fund
S&P 500
This Quarter Est. Return
-3.96%
1 Year Est. Return
+22.01%
3 Year Est. Return
+63.17%
5 Year Est. Return
+74.8%
10 Year Est. Return
+385.76%
AUM
$390B
AUM Growth
-$10.7B
Cap. Flow
+$10.1B
Cap. Flow %
2.59%
Top 10 Hldgs %
17.89%
Holding
8,421
New
408
Increased
2,815
Reduced
3,298
Closed
614

Sector Composition

Rank Sector Weight
1 Technology 14.98%
2 Healthcare 8.57%
3 Financials 7.65%
4 Industrials 6.74%
5 Consumer Discretionary 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GALT icon
5926
Galectin Therapeutics
GALT
$315M
$13K ﹤0.01%
8,504
+1
+0% +$2
IDN icon
5927
Intellicheck
IDN
$76.1M
$13K ﹤0.01%
5,102
-25,696
-83% -$93.7K
FDIQ
5928
Invesco Bloomberg Financial Data Providers ETF
FDIQ
$48.3M
$13K ﹤0.01%
214
KELYB
5929
Kelly Services Class B
KELYB
$792M
$13K ﹤0.01%
585
-3
-0.5% -$60
NERV icon
5930
Minerva Neurosciences
NERV
$221M
$13K ﹤0.01%
1,969
+1,875
+1,995% +$11.5K
NPCE icon
5931
Neuropace
NPCE
$507M
$13K ﹤0.01%
1,596
-2,475
-61% -$21.4K
NVNO
5932
enVVeno Medical
NVNO
$6.93M
$13K ﹤0.01%
58
PL icon
5933
Planet Labs
PL
$8.23B
$13K ﹤0.01%
2,415
+1,015
+73% +$5.6K
PXLW icon
5934
Pixelworks
PXLW
$41M
$13K ﹤0.01%
367
+308
+522% +$12.2K
RGTI icon
5935
Rigetti Computing
RGTI
$5.89B
$13K ﹤0.01%
+2,000
New +$17.8K
SLDB icon
5936
Solid Biosciences
SLDB
$918M
$13K ﹤0.01%
754
-1,459
-66% -$25.7K
TNXP icon
5937
Tonix Pharmaceuticals
TNXP
$201M
0
UAPR icon
5938
Innovator US Equity Ultra Buffer ETF April
UAPR
$159M
$13K ﹤0.01%
489
XOS icon
5939
Xos
XOS
$37M
$13K ﹤0.01%
144
+33
+30% +$2.48K
TBNK
5940
DELISTED
Territorial Bancorp Inc.
TBNK
$13K ﹤0.01%
553
+1
+0.2% +$25
AFIB
5941
DELISTED
Acutus Medical Inc
AFIB
$13K ﹤0.01%
9,200
-6,666
-42% -$14.3K
CYT
5942
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$13K ﹤0.01%
3,561
-875
-20% -$4.98K
NMRD
5943
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$13K ﹤0.01%
3,106
+2,050
+194% +$8.57K
SGTX
5944
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$13K ﹤0.01%
690
-410
-37% -$9.14K
PSTH.WS
5945
DELISTED
Pershing Square Tontine Holdings, Ltd. Warrants, exercisable for one share of Class A Common Stock f
PSTH.WS
$13K ﹤0.01%
14,082
-60
-0.4% -$73
SRAX
5946
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$13K ﹤0.01%
2,637
+6
+0.2% +$28
BKIE icon
5947
BNY Mellon International Equity ETF
BKIE
$1.34B
$12K ﹤0.01%
+525
New +$12.4K
BUFR icon
5948
FT Vest Fund of Buffer ETFs
BUFR
$10.4B
$12K ﹤0.01%
511
GPGI
5949
GPGI Inc
GPGI
$4.16B
$12K ﹤0.01%
1,994
+1,753
+727% +$10.9K
COEPW
5950
DELISTED
Coeptis Therapeutics Warrants
COEPW
$12K ﹤0.01%
152,454

Similar funds

Wells Fargo's Q1 2022 Portfolio in Review

As of Q1 2022, Wells Fargo held 8,421 positions worth $390B, down 2.7% from $401B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Wells Fargo's Q1 2022 filing shows 408 new, 2,815 increased, 3,298 reduced and 614 closed positions. Its largest new stake was Shell: 1,908,046 shares worth $105M. The largest sale was iShares Russell 2000 ETF, an estimated $408M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Wells Fargo's largest Q1 2022 buy was Shell: 1,908,046 shares worth $105M.
  • Wells Fargo added most to State Street Financial Select Sector SPDR ETF in Q1 2022, an estimated $941M increase.
  • Wells Fargo's biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $408M.
  • Wells Fargo fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $173M.
  • Wells Fargo's ten largest holdings make up 18% of its $390B portfolio in Q1 2022.
  • Wells Fargo opened 408 new positions and closed 614 in Q1 2022.
  • Wells Fargo's portfolio value fell 2.7% quarter-over-quarter to $390B.

Based on Wells Fargo's 13F filing for Q1 2022, filed 16 May 2022.